PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

RATIONALE: Vaccines may make the body build an immune response to kill tumor cells. PURPOSE: Randomized phase II trial to study the effectiveness of different regimens of PSA vaccines in treating patients who have advanced prostate cancer.

Key facts

Study ID

NCT00003871

Run by

Eastern Cooperative Oncology Group

People needed

60

Starts

1999-09-24

Last updated by the study team

2023-06-22

Who can join

Age: 18 and older, up to 120. Sex: male. Healthy volunteers: not accepted.

Where it is running

• Indiana University Cancer Center — Indianapolis, Indiana, United States
• Veterans Affairs Medical Center - Indianapolis (Roudebush) — Indianapolis, Indiana, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
• Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
• Albert Einstein Comprehensive Cancer Center — The Bronx, New York, United States
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States
• University of Pittsburgh Cancer Institute — Pittsburgh, Pennsylvania, United States
• Vanderbilt Cancer Center — Nashville, Tennessee, United States
• Veterans Affairs Medical Center - Madison — Madison, Wisconsin, United States
• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.